Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Publication year range
1.
Arch Ital Biol ; 152(2-3): 118-28, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25828684

RESUMEN

Rapid eye movement sleep behavior disorder (RBD) is a parasomnia characterized by the loss of muscle atonia during paradoxical (REM) sleep (PS). Conversely, cataplexy, one of the key symptoms of narcolepsy, is a striking sudden episode of muscle weakness triggered by emotions during wakefulness, and comparable to REM sleep atonia. The neuronal dysfunctions responsible for RBD and cataplexy are not known. In the present review, we present the most recent results on the neuronal network responsible for PS. Based on these results, we propose an updated integrated model of the mechanisms responsible for PS and explore different hypotheses explaining RBD and cataplexy. We propose that RBD is due to a specific degeneration of a subpopulation of PS-on glutamatergic neurons specifically responsible of muscle atonia, localized in the caudal pontine sublaterodorsal tegmental nucleus (SLD). Another possibility is the occurrence in RBD patients of a specific lesion of the glycinergic/GABAergic premotor-neurons localized in the medullary ventral gigantocellular reticular nucleus. Conversely, cataplexy in narcoleptics would be due to the activation during waking of the caudal PS-on SLD neurons responsible for muscle atonia. A direct or indirect pathway activated during positive emotion from the central amygdala to the SLD PS-on neurons would induce such activation. In normal conditions, the activation of SLD neurons would be blocked by the simultaneous excitation by the hypocretins of the PS-off GABAergic neurons localized in the ventrolateral periaqueductal gray and the adjacent deep mesencephalic reticular nucleus gating the activation of the PS-on SLD neurons.


Asunto(s)
Encéfalo/metabolismo , Narcolepsia/fisiopatología , Trastorno de la Conducta del Sueño REM/fisiopatología , Animales , Encéfalo/fisiología , Modelos Animales de Enfermedad , Humanos , Narcolepsia/etiología , Narcolepsia/metabolismo , Neurotransmisores/metabolismo , Trastorno de la Conducta del Sueño REM/etiología , Trastorno de la Conducta del Sueño REM/metabolismo
2.
Drug Intell Clin Pharm ; 17(7-8): 580-90, 1983.
Artículo en Inglés | MEDLINE | ID: mdl-6872863

RESUMEN

A systematic reference of English-Spanish prescription label translations is presented. The purpose of the reference list (which is the most comprehensive published to date) is to enable a pharmacist to write precise, accurate label directions in Spanish for any patient who cannot read English.


Asunto(s)
Etiquetado de Medicamentos , Lenguaje
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda